Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.

Clerici E, Comito T, Franzese C, Di Brina L, Tozzi A, Iftode C, Navarria P, Mancosu P, Reggiori G, Tomatis S, Scorsetti M.

Strahlenther Onkol. 2019 Oct 11. doi: 10.1007/s00066-019-01524-8. [Epub ahead of print]

PMID:
31605163
2.

Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients with Large Brain Metastases. Results of a Phase 2 Study.

Navarria P, Pessina F, Clerici E, Franceschini D, Gay LG, De Rose F, Renna I, D'Agostino G, Franzese C, Comito T, Tomatis S, Nibali MC, Leonetti A, Puglisi G, Bello L, Scorsetti M.

Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33743-5. doi: 10.1016/j.ijrobp.2019.08.054. [Epub ahead of print]

PMID:
31479701
3.

Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy.

D'Agostino GR, Di Brina L, Mancosu P, Franzese C, Iftode C, Franceschini D, Clerici E, Tozzi A, Navarria P, Scorsetti M.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):614-621. doi: 10.1016/j.ijrobp.2019.02.041. Epub 2019 Feb 27.

PMID:
30825495
4.

Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.

Cozzi L, Comito T, Fogliata A, Franzese C, Franceschini D, Bonifacio C, Tozzi A, Di Brina L, Clerici E, Tomatis S, Reggiori G, Lobefalo F, Stravato A, Mancosu P, Zerbi A, Sollini M, Kirienko M, Chiti A, Scorsetti M.

PLoS One. 2019 Jan 18;14(1):e0210758. doi: 10.1371/journal.pone.0210758. eCollection 2019.

5.

Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P, Galaverni M, Amelio D, Scartoni D, Scoccianti S, Krengli M, Masini L, Draghini L, Maranzano E, Borzillo V, Muto P, Ferrarese F, Fariselli L, Livi L, Pasqualetti F, Fiorentino A, Alongi F, di Monale MB, Magrini S, Scorsetti M.

J Neurooncol. 2019 Mar;142(1):59-67. doi: 10.1007/s11060-018-03059-x. Epub 2018 Dec 4.

PMID:
30515706
6.

Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.

Pessina F, Navarria P, Clerici E, Soffietti R, Nibali MC, Rudà R, Riva M, Scorsetti M, Bello L.

World Neurosurg. 2019 Mar;123:e273-e279. doi: 10.1016/j.wneu.2018.11.150. Epub 2018 Nov 26.

PMID:
30496926
7.

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up.

Scorsetti M, Comito T, Clerici E, Franzese C, Tozzi A, Iftode C, Di Brina L, Navarria P, Mancosu P, Reggiori G, Fogliata A, Tomatis S, Torzilli G, Cozzi L.

Radiat Oncol. 2018 Nov 26;13(1):234. doi: 10.1186/s13014-018-1185-9.

8.

Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.

Franzese C, Comito T, Toska E, Tozzi A, Clerici E, De Rose F, Franceschini D, Navarria P, Reggiori G, Tomatis S, Scorsetti M.

Radiother Oncol. 2019 Apr;133:220-226. doi: 10.1016/j.radonc.2018.10.024. Epub 2018 Nov 7.

PMID:
30414754
9.

Gynecomastia after euthyroidism restoration in a patient with type 1 diabetes and Graves' disease.

Calcaterra V, Clerici E, Ceolin V, Regalbuto C, Larizza D.

Clin Case Rep. 2018 Jun 14;6(8):1481-1484. doi: 10.1002/ccr3.1565. eCollection 2018 Aug.

10.

Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis.

Navarria P, Pessina F, Cozzi L, Tomatis S, Reggiori G, Simonelli M, Santoro A, Clerici E, Franzese C, Carta G, Conti Nibali M, Bello L, Scorsetti M.

Tumori. 2019 Feb;105(1):47-54. doi: 10.1177/0300891618792483. Epub 2018 Aug 22.

PMID:
30131010
11.

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment.

Pessina F, Navarria P, Cozzi L, Rudà R, Nibali MC, Simonelli M, Costa F, Santoro A, Clerici E, Carta G, Scorsetti M, Bello L.

Acta Neurochir (Wien). 2018 Sep;160(9):1779-1787. doi: 10.1007/s00701-018-3599-4. Epub 2018 Jul 3.

PMID:
29971562
12.

Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation.

Franzese C, Comito T, Clerici E, Di Brina L, Tomatis S, Navarria P, Reggiori G, Viganò L, Poretti D, Pedicini V, Torzilli G, Solbiati L, Scorsetti M.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1777-1783. doi: 10.1007/s00432-018-2692-7. Epub 2018 Jun 22.

PMID:
29934790
13.

Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy.

Pessina F, Navarria P, Carta GA, D'Agostino GR, Clerici E, Nibali MC, Costa F, Fornari M, Scorsetti M.

World Neurosurg. 2018 Jul;115:e681-e687. doi: 10.1016/j.wneu.2018.04.136. Epub 2018 Apr 27.

PMID:
29709741
14.

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

Navarria P, Pessina F, Franzese C, Tomatis S, Perrino M, Cozzi L, Simonelli M, Bello L, Clerici E, Riva M, Santoro A, Scorsetti M.

Radiother Oncol. 2018 Apr;127(1):108-113. doi: 10.1016/j.radonc.2017.12.006. Epub 2017 Dec 29.

PMID:
29291951
15.

Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis.

Pessina F, Navarria P, Cozzi L, Franceschini D, Tomatis S, Clerici E, Ascolese AM, DE Rose F, Bello L, Masci G, Santoro A, Scorsetti M.

Anticancer Res. 2017 Dec;37(12):7057-7062.

PMID:
29187495
16.

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study.

Navarria P, Pessina F, Tomatis S, Soffietti R, Grimaldi M, Lopci E, Chiti A, Leonetti A, Casarotti A, Rossi M, Cozzi L, Ascolese AM, Simonelli M, Marcheselli S, Santoro A, Clerici E, Bello L, Scorsetti M.

Oncotarget. 2017 Jun 28;8(40):67696-67708. doi: 10.18632/oncotarget.18809. eCollection 2017 Sep 15.

17.

Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.

Franzese C, Fogliata A, Comito T, Tozzi A, Iftode C, Clerici E, Franceschini D, Navarria P, Ascolese AM, Di Brina L, De Rose F, D'Agostino GR, Cozzi L, Scorsetti M.

Br J Radiol. 2017 Nov;90(1079):20170422. doi: 10.1259/bjr.20170422. Epub 2017 Oct 3.

18.

Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

Pessina F, Navarria P, Cozzi L, Tomatis S, Clerici E, Ascolese AM, Simonelli M, Perrino M, Riva M, Rossi M, Rudà R, Santoro A, Bello L, Scorsetti M.

CNS Oncol. 2017 Jul 18. doi: 10.2217/cns-2016-0043. [Epub ahead of print]

19.

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Clerici E, Rossi M, Scorsetti M, Bello L.

J Neurooncol. 2017 Oct;135(1):129-139. doi: 10.1007/s11060-017-2559-9. Epub 2017 Jul 8.

PMID:
28689368
20.

Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform.

Ciardo D, Argenone A, Boboc GI, Cucciarelli F, De Rose F, De Santis MC, Huscher A, Ippolito E, La Porta MR, Marino L, Meaglia I, Palumbo I, Rossi F, Alpi P, Bignardi M, Bonanni A, Cante D, Ceschia T, Fabbietti L, Lupattelli M, Mantero ED, Monaco A, Porcu P, Ravo V, Silipigni S, Tozzi A, Umina V, Zerini D, Bordonaro L, Capezzali G, Clerici E, Colangione SP, Dispinzieri M, Dognini J, Donadoni L, Falivene S, Fozza A, Grilli B, Guarnaccia R, Iannacone E, Lancellotta V, Prisco A, Ricotti R, Orecchia R, Jereczek-Fossa BA, Leonardi MC; on the behalf of the Breast Working Group of the Italian Association of Radiation Oncology (AIRO).

Acta Oncol. 2017 Aug;56(8):1081-1088. doi: 10.1080/0284186X.2017.1325004. Epub 2017 May 23.

PMID:
28534430
21.

Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours.

Franceschini D, Cozzi L, De Rose F, Navarria P, Franzese C, Comito T, Iftode C, Tozzi A, Di Brina L, Ascolese AM, Clerici E, D'Agostino G, Fogliata A, Scorsetti M.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1293-1299. doi: 10.1007/s00432-017-2373-y. Epub 2017 Mar 3.

PMID:
28258344
22.

Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer : A retrospective study of elderly patients with stage III disease.

Franceschini D, De Rose F, Cozzi L, Navarria P, Clerici E, Franzese C, Comito T, Tozzi A, Iftode C, D'Agostino G, Sorsetti M.

Strahlenther Onkol. 2017 May;193(5):385-391. doi: 10.1007/s00066-017-1103-3. Epub 2017 Feb 6.

PMID:
28168322
23.

Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study.

Comito T, Cozzi L, Zerbi A, Franzese C, Clerici E, Tozzi A, Iftode C, Navarria P, D'Agostino G, Fogliata A, Mancosu P, Tomatis S, Carnaghi C, Personeni N, Santoro A, Scorsetti M.

Eur J Surg Oncol. 2017 Apr;43(4):735-742. doi: 10.1016/j.ejso.2016.12.012. Epub 2017 Jan 16.

PMID:
28131670
24.

Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease.

Franceschini D, De Rose F, Fogliata A, Navarria P, Ascolese AM, Franzese C, Comito T, Tozzi A, Iftode C, Di Brina L, D'Agostino G, Clerici E, Cozzi L, Scorsetti M.

Oncotarget. 2016 Aug 16;7(33):53321-53329. doi: 10.18632/oncotarget.10826.

25.

Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma.

Franzese C, Fogliata A, Franceschini D, Clerici E, D'Agostino G, Navarria P, Mancosu P, Tomatis S, Cozzi L, Scorsetti M.

Anticancer Res. 2016 Jul;36(7):3451-7.

PMID:
27354607
26.

Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.

Comito T, Cozzi L, Clerici E, Franzese C, Tozzi A, Iftode C, Navarria P, D'Agostino G, Rimassa L, Carnaghi C, Personeni N, Tronconi MC, De Rose F, Franceschini D, Ascolese AM, Fogliata A, Tomatis S, Santoro A, Zerbi A, Scorsetti M.

Technol Cancer Res Treat. 2017 Jun;16(3):295-301. doi: 10.1177/1533034616650778. Epub 2016 Jun 16.

27.

Stem Cell Regulation by Arabidopsis WOX Genes.

Dolzblasz A, Nardmann J, Clerici E, Causier B, van der Graaff E, Chen J, Davies B, Werr W, Laux T.

Mol Plant. 2016 Jul 6;9(7):1028-39. doi: 10.1016/j.molp.2016.04.007. Epub 2016 Apr 19.

28.

Liver metastases and SBRT: A new paradigm?

Comito T, Clerici E, Tozzi A, D'Agostino G.

Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):464-71. doi: 10.1016/j.rpor.2014.10.002. Epub 2014 Nov 6.

29.

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.

Franzese C, Fogliata A, Clerici E, Franceschini D, Villa E, D'Agostino G, Navarria P, Mancosu P, Tomatis S, Cozzi L, Scorsetti M.

Radiat Oncol. 2015 Nov 6;10:224. doi: 10.1186/s13014-015-0535-0.

30.

Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients.

De Rose F, Cozzi L, Navarria P, Ascolese AM, Clerici E, Infante M, Alloisio M, Testori A, Toschi L, Finocchiaro G, Santoro A, Scorsetti M.

Clin Oncol (R Coll Radiol). 2016 Jan;28(1):13-20. doi: 10.1016/j.clon.2015.08.011. Epub 2015 Sep 15.

PMID:
26385822
31.

The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.

Scorsetti M, Clerici E, Navarria P, D'Agostino G, Piergallini L, De Rose F, Ascolese A, Tozzi A, Iftode C, Villa E, Comito T, Franzese C, Mancosu P, Tomatis S, Cozzi L.

Br J Radiol. 2015 Sep;88(1053):20150111. doi: 10.1259/bjr.20150111. Epub 2015 Jul 17.

32.

Neoadjuvant Chemoradiotherapy with Volumetric-modulated Arc Therapy for Medium-distal Oesophageal and Gastro-oesophageal Junction Carcinoma.

Tozzi A, Iftode C, Cozzi L, Ascolese AM, Battista S, Cavina R, Clerici E, Comito T, D'Agostino GR, De Rose F, Franzese C, Garassino I, Romario UF, Navarria P, Rosati R, Spaggiari P, Tomatis S, Scorsetti M.

Anticancer Res. 2015 Jul;35(7):4109-16.

PMID:
26124363
33.

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

Scorsetti M, Navarria P, Pessina F, Ascolese AM, D'Agostino G, Tomatis S, De Rose F, Villa E, Maggi G, Simonelli M, Clerici E, Soffietti R, Santoro A, Cozzi L, Bello L.

BMC Cancer. 2015 Jun 30;15:486. doi: 10.1186/s12885-015-1488-2.

34.

Hypofractionated stereotactic radiation therapy in skull base meningiomas.

Navarria P, Pessina F, Cozzi L, Clerici E, Villa E, Ascolese AM, De Rose F, Comito T, Franzese C, D'Agostino G, Lobefalo F, Fogliata A, Reggiori G, Fornari M, Tomatis S, Bello L, Scorsetti M.

J Neurooncol. 2015 Sep;124(2):283-9. doi: 10.1007/s11060-015-1838-6. Epub 2015 Jun 4.

PMID:
26040487
35.

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge.

Navarria P, Ascolese AM, Tomatis S, Reggiori G, Clerici E, Villa E, Maggi G, Bello L, Pessina F, Cozzi L, Scorsetti M.

Cancer Res Treat. 2016 Jan;48(1):37-44. doi: 10.4143/crt.2014.259. Epub 2015 Feb 23.

36.

Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.

Schinkelshoek M, Lopci E, Clerici E, Alongi F, Mancosu P, Rodari M, Navarria P, van der Hiel B, Scorsetti M, Chiti A.

Tumori. 2014 Nov-Dec;100(6):636-44. doi: 10.1700/1778.19268. Erratum in: Tumori. 2018 Dec;104(6):480.

PMID:
25688497
37.

The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).

Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D'Agostino G, Iftode C, Mancosu P, Ceriani R, Torzilli G.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1301-9. doi: 10.1007/s00432-015-1929-y. Epub 2015 Feb 3.

PMID:
25644863
38.

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy.

Tozzi A, Cozzi L, Iftode C, Ascolese A, Campisi MC, Clerici E, Comito T, De Rose F, Fogliata A, Franzese C, Mancosu P, Navarria P, Tomatis S, Villa E, Scorsetti M.

BMC Cancer. 2014 Nov 18;14:833. doi: 10.1186/1471-2407-14-833.

39.

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma.

Navarria P, Reggiori G, Pessina F, Ascolese AM, Tomatis S, Mancosu P, Lobefalo F, Clerici E, Lopci E, Bizzi A, Grimaldi M, Chiti A, Simonelli M, Santoro A, Bello L, Scorsetti M.

Radiother Oncol. 2014 Sep;112(3):425-9. doi: 10.1016/j.radonc.2014.09.004. Epub 2014 Oct 9.

PMID:
25308182
40.

Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer.

Scorsetti M, Comito T, Tozzi A, Navarria P, Fogliata A, Clerici E, Mancosu P, Reggiori G, Rimassa L, Torzilli G, Tomatis S, Santoro A, Cozzi L.

J Cancer Res Clin Oncol. 2015 Mar;141(3):543-53. doi: 10.1007/s00432-014-1833-x. Epub 2014 Sep 23.

PMID:
25245052
41.

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.

Comito T, Cozzi L, Clerici E, Campisi MC, Liardo RL, Navarria P, Ascolese A, Tozzi A, Iftode C, De Rose F, Villa E, Personeni N, Rimassa L, Santoro A, Fogliata A, Mancosu P, Tomatis S, Scorsetti M.

BMC Cancer. 2014 Aug 27;14:619. doi: 10.1186/1471-2407-14-619.

42.

Stereotactic body radiation therapy for liver metastases.

Scorsetti M, Clerici E, Comito T.

J Gastrointest Oncol. 2014 Jun;5(3):190-7. doi: 10.3978/j.issn.2078-6891.2014.039. Review.

43.

Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.

Scorsetti M, Navarria P, De Rose F, Ascolese A, Clerici E, Franzese C, Lobefalo F, Reggiori G, Mancosu P, Tomatis S, Fogliata A, Cozzi L.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1937-45. doi: 10.1007/s00432-014-1739-7. Epub 2014 Jun 17.

PMID:
24934724
44.

Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of life.

Scorsetti M, Alongi F, Clerici E, Comito T, Fogliata A, Iftode C, Mancosu P, Navarria P, Reggiori G, Tomatis S, Villa E, Cozzi L.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1795-800. doi: 10.1007/s00432-014-1732-1. Epub 2014 Jun 7.

PMID:
24906878
45.

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments.

Navarria P, Ascolese AM, Tomatis S, Cozzi L, De Rose F, Mancosu P, Alongi F, Clerici E, Lobefalo F, Tozzi A, Reggiori G, Fogliata A, Scorsetti M.

Radiat Oncol. 2014 Apr 2;9(1):91. doi: 10.1186/1748-717X-9-91.

46.

Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.

Alongi F, Cozzi L, Fogliata A, Iftode C, Comito T, Clivio A, Villa E, Lobefalo F, Navarria P, Reggiori G, Mancosu P, Clerici E, Tomatis S, Taverna G, Graziotti P, Scorsetti M.

Anticancer Res. 2013 Oct;33(10):4537-43.

PMID:
24123027
47.

Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study.

Alongi F, Cozzi L, Arcangeli S, Iftode C, Comito T, Villa E, Lobefalo F, Navarria P, Reggiori G, Mancosu P, Clerici E, Fogliata A, Tomatis S, Taverna G, Graziotti P, Scorsetti M.

Radiat Oncol. 2013 Jul 8;8:171. doi: 10.1186/1748-717X-8-171.

48.

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

Tozzi A, Comito T, Alongi F, Navarria P, Iftode C, Mancosu P, Reggiori G, Clerici E, Rimassa L, Zerbi A, Fogliata A, Cozzi L, Tomatis S, Scorsetti M.

Radiat Oncol. 2013 Jun 21;8:148. doi: 10.1186/1748-717X-8-148.

49.

Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).

Navarria P, Ascolese AM, Mancosu P, Alongi F, Clerici E, Tozzi A, Iftode C, Reggiori G, Tomatis S, Infante M, Alloisio M, Testori A, Fogliata A, Cozzi L, Morenghi E, Scorsetti M.

Radiother Oncol. 2013 Jun;107(3):414-8. doi: 10.1016/j.radonc.2013.04.016. Epub 2013 May 28.

PMID:
23725859
50.

Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients.

Alongi F, Fogliata A, Clerici E, Navarria P, Tozzi A, Comito T, Ascolese AM, Clivio A, Lobefalo F, Reggiori G, Cozzi L, Mancosu P, Tomatis S, Scorsetti M.

Radiat Oncol. 2012 Dec 5;7:204. doi: 10.1186/1748-717X-7-204.

Supplemental Content

Loading ...
Support Center